β-Arrestin1 promotes the self-renewal of the leukemia-initiating cell-enriched subpopulation in B-lineage acute lymphoblastic leukemia related to DNMT1 activity

Cancer Letters

Volumn 357, Issue 1, 2015, Pages 170-178

  Shu, Yi ^a   Zhou, Xiaoyan ^a   Qi, Xinkun ^a   Liu, Shan ^a   Li, Kang ^a   Tan, Junjie ^a   Liu, Zhidai ^a   Yu, Jie ^a   Zhang, Penghui ^a   Zou, Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

B lineage acute lymphocytic leukemia; DNA methyltransferases; Leukemia initiating cells enriched fraction; Self renewal; Arrestin1

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; BETA CATENIN; CD19 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA; DNA METHYLTRANSFERASE 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MYB; PROTEIN P53; TRANSCRIPTION FACTOR HOXA9; BETA ARRESTIN; DMAP1 PROTEIN, HUMAN; PTEN PROTEIN, HUMAN; REPRESSOR PROTEIN; RETINA S ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; B CELL LEUKEMIA; CANCER STEM CELL; CELL PROLIFERATION; CELL RENEWAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; SCHOOL CHILD; ANIMAL; APOPTOSIS; BIOSYNTHESIS; ENZYMOLOGY; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; XENOGRAFT;

ADOLESCENT; ANIMALS; APOPTOSIS; ARRESTINS; CHILD; DNA METHYLATION; FEMALE; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PTEN PHOSPHOHYDROLASE; REPRESSOR PROTEINS;

EID: 84920434344     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.025     Document Type: Article

References (40)

1. Lefkowitz R.J., Whalen E.J. beta-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol 2004, 6:162-168.
2. Shenoy S.K., Lefkowitz R.J. beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci 2011, 32:521-533.
3. Kang J., Shi Y., Xiang B., Qu B., Su W., Zhu M., et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 2005, 123:833-847.
4. Yue R., Kang J., Zhao C., Hu W., Tang Y., Liu X., et al. Beta-arrestin1 regulates zebrafish hematopoiesis through binding to YY1 and relieving polycomb group repression. Cell 2009, 139:535-546.
5. Fereshteh M., Ito T., Kovacs J.J., Zhao C., Kwon H.Y., Tornini V., et al. beta-Arrestin2 mediates the initiation and progression of myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12532-12537.
6. Qin R., Li K., Qi X., Zhou X., Wang L., Zou L., et al. beta-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR/ABL H4 acetylation. Br. J. Cancer 2014, 111:568-576.
7. Liu H., Long J., Zhang P.H., Li K., Tan J.J., Sun B., et al. Elevated beta-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia. Int. J. Hematol 2011, 93:494-501.
8. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med 2006, 355:1253-1261.
9. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
10. Cobaleda C., Sanchez-Garcia I. B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays 2009, 31:600-609.
11. le Viseur C., Hotfilder M., Bomken S., Wilson K., Rottgers S., Schrauder A., et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 2008, 14:47-58.
12. Kong Y., Yoshida S., Saito Y., Doi T., Nagatoshi Y., Fukata M., et al. CD34 + CD38 + CD19+ as well as CD34 + CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 2008, 22:1207-1213.
13. Morisot S., Wayne A.S., Bohana-Kashtan O., Kaplan I.M., Gocke C.D., Hildreth R., et al. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia 2010, 24:1859-1866.
14. Castor A., Nilsson L., Astrand-Grundstrom I., Buitenhuis M., Ramirez C., Anderson K., et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat. Med 2005, 11:630-637.
15. Hong D., Gupta R., Ancliff P., Atzberger A., Brown J., Soneji S., et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008, 319:336-339.
16. Roman-Gomez J., Jimenez-Velasco A., Castillejo J.A., Agirre X., Barrios M., Navarro G., et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004, 104:2492-2498.
17. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
18. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.
19. Trowbridge J.J., Orkin S.H. Dnmt3a silences hematopoietic stem cell self-renewal. Nat. Genet 2011, 44:13-14.
20. Trowbridge J.J., Snow J.W., Kim J., Orkin S.H. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 2009, 5:442-449.
21. Tsai H.C., Li H., Van Neste L., Cai Y., Robert C., Rassool F.V., et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 2012, 21:430-446.
22. Bian E.B., Huang C., Ma T.T., Tao H., Zhang H., Cheng C., et al. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol. Appl. Pharmacol 2012, 264:13-22.
23. Hino R., Uozaki H., Murakami N., Ushiku T., Shinozaki A., Ishikawa S., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009, 69:2766-2774.
24. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
25. Nilsson L., Astrand-Grundstrom I., Anderson K., Arvidsson I., Hokland P., Bryder D., et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002, 100:259-267.
26. Hong D., Gupta R., Ancliff P., Atzberger A., Brown J., Soneji S., et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008, 319(5861):336-339.
27. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol 2006, 7:139-147.
28. Lagadinou E.D., Sach A., Callahan K., Rossi R.M., Neering S.J., Minhajuddin M., et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 2013, 12:329-341.
29. Palii C.G., Pasha R., Brand M. Lentiviral-mediated knockdown during ex vivo erythropoiesis of human hematopoietic stem cells. J. Vis. Exp 2011, 53. 2813.
30. Huntly B.J., Gilliland D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 2005, 5:311-321.
31. Akala O.O., Park I.K., Qian D., Pihalja M., Becker M.W., Clarke M.F. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature 2008, 453:228-232.
32. Greig K.T., Carotta S., Nutt S.L. Critical roles for c-Myb in hematopoietic progenitor cells. Semin. Immunol 2008, 20:247-256.
33. Reynaud D., Ravet E., Titeux M., Mazurier F., Renia L., Dubart-Kupperschmitt A., et al. SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood 2005, 106:2318-2328.
34. Moran-Crusio K.1., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C., et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20(1):11-24.
35. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 2007, 128:735-745.
36. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439:871-874.
37. Milani L., Lundmark A., Kiialainen A., Nordlund J., Flaegstad T., Forestier E., et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 2010, 115:1214-1225.
38. Davidsson J., Lilljebjorn H., Andersson A., Veerla S., Heldrup J., Behrendtz M., et al. The DNA methylome of pediatric acute lymphoblastic leukemia. Hum. Mol. Genet 2009, 18:4054-4065.
39. Peng C., Chen Y., Yang Z., Zhang H., Osterby L., Rosmarin A.G., et al. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice. Blood 2010, 115:626-635.
40. Silva A., Yunes J.A., Cardoso B.A., Martins L.R., Jotta P.Y., Abecasis M., et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J. Clin. Invest 2008, 118:3762-3774.